Tonghua Dongbao Pharmaceutical Co., Ltd.
Clinical trials sponsored by Tonghua Dongbao Pharmaceutical Co., Ltd., explained in plain language.
A Chinese pharmaceutical company focused on diabetes and endocrine drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New insulin candidate tested in 1,040 chinese diabetes patients
Disease control CompletedThis study tested a new insulin called THDB0206 against a standard insulin (lispro) in 1,040 Chinese adults with type 2 diabetes. Both were used alongside a long-acting insulin. The goal was to see if the new insulin works as well or better at controlling blood sugar over 26 week…
Phase 3 • Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New insulin shows promise for type 1 diabetes in chinese trial
Disease control CompletedThis Phase 3 trial tested a new fast-acting insulin called THDB0206 against a standard insulin (lispro) in 550 Chinese adults with type 1 diabetes. Both groups also used a long-acting insulin (glargine). The main goal was to see if THDB0206 could control blood sugar (HbA1c) as we…
Phase 3 • Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Where you inject matters: new study tests insulin at three sites
Knowledge-focused CompletedThis completed Phase 1 study looked at how a single dose of the insulin drug THDB0206 behaves when injected into the upper arm, abdomen, or thigh. Twenty-seven healthy Chinese adults each received the same dose at all three sites in a random order. The goal was to see if the inje…
Phase 1 • Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC